Biomarker-based steroid reduction difficult to achieve in real world

Use of a biomarker-based strategy to safely reduce corticosteroid use in severe asthma did not show a significant impact – possibly because a high number of patients failed to follow treatment advice, according to UK researchers. Presenting their results at the European Respiratory Society 2020 Virtual Conference, they said it had been hoped that use ...